Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Gynecologic Neoplasms 12. February 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 16216  Previews Next
   
   Articles 1 - 20 / 324301  
   
Muscle quality during cancer treatment and associations with health-related quality of life.
Qual Life Res
Rodrigues JL, O'Connell NS, Sutton AL, Ruddy KJ, Weaver KE, Lesser GJ, Ky B, D'Agostino RB Jr, Hundley WG, Bellissimo MP.
PMID: 41678067 [PubMed - indexed for MEDLINE]


Understanding, Recognizing, and Managing Cancer-Related Fatigue Associated with Breast Cancer.
Curr Treat Options Oncol
Peng L, Wang X, Zhang C, Liu T, Luo X, Li Z.
PMID: 41678031 [PubMed - in process]


Axillary Extranodal Extension in Breast Cancer: Imaging Features With Histopathology Correlation.
J Breast Imaging
Nguyen PT, Portnow LH, Packer MD, Gombos EC.
PMID: 41677770 [PubMed - as supplied by publisher]


Extracellular Vesicle Associated Proteomic Biomarkers in Breast Cancer: A Systematic Review and Meta-Analysis.
Cells
Al-Mahrouqi N, Al-Sayegh H, Al-Zadjali S, Khan AA.
PMID: 41677598 [PubMed - indexed for MEDLINE]


Prevalence of BRCA1 and BRCA2 Germline Mutations in Vietnamese Patients With Triple-Negative Breast Cancer.
Cancer Control
Toan TT, To TV, Lan TTH, Thinh NV, Anh DTN, Hanh BTM.
PMID: 41676859 [PubMed - indexed for MEDLINE]


Clinical outcome and tolerability of DS-8201 in patients with advanced HER2-positive breast cancer: a retrospective study.
Am J Transl Res
Wu W, Zhang R, Zhao Y, Lu X.
PMID: 41676255 [PubMed]


Development and validation of an interpretable machine learning model identify the lactylation-related protein SUSD3 as a prognostic and therapeutic biomarker for breast cancer.
Front Immunol
Tang L.
PMID: 41676158 [PubMed - indexed for MEDLINE]


Integrative bioinformatics approaches for early detection biomarkers in ovarian cancer.
Ann Med Surg (Lond)
Obeagu EI.
PMID: 41675779 [PubMed]


Thrombopoiesis meets tumorigenesis: unlocking the diagnostic and prognostic potential of platelet indices in breast cancer- a narrative review.
Ann Med Surg (Lond)
Obeagu EI.
PMID: 41675754 [PubMed]


Radiologic imaging and its current importance in breast cancer management.
Front Radiol
Dagar N, Sarin M, Yadav P, Thidwar R.
PMID: 41675437 [PubMed]


Immuno-oncological effects of aerobic exercise combined with anti-PD-L1 antibody blockade in a murine breast cancer model.
Front Oncol
Hekmatikar AA, Agha-Alinejad H, Yousefi-Ahmadipour A, Shamsi MM, Daud DMA.
PMID: 41675286 [PubMed]


BRCA and CDK4/6: allies or antagonists?-efficacy of CDK4/6 inhibitors in HR(+)/HER2(-) breast cancer with germline BRCA1/2 mutations: a narrative review.
Transl Breast Cancer Res
Illia MF, Colucci G, Rodriguez Mignola A, Eiben M, Ballester AM, Zeff N, Paesani F, Crimi G, Von Stecher F, de la Vega M, Perazzo F, Mandó P.
PMID: 41675010 [PubMed]


Chinese expert consensus on endocrine therapy for breast cancer (2026 edition).
Transl Breast Cancer Res
Yuan Y, Yin Y, Wang S, Liu Y, Yang J, Yan M, Mo X, Pan Y, Wang X, Wang H, Li J, Wang S, Wu J, Song E, Jiang Z, Chinese Consensus Group on Breast Cancer Endocrine Therapy.
PMID: 41675009 [PubMed]


The preliminary study on the effect of PSEN1 on the proliferation and invasion of breast cancer cells.
Transl Breast Cancer Res
Yang M, Zou JQ, Yang W.
PMID: 41675007 [PubMed]


Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review.
Transl Breast Cancer Res
Stravodimou A, Voutsadakis IA.
PMID: 41675006 [PubMed]


Real-world efficacy and prognostic factors of CDK4/6 inhibitors in HR(+)/HER2(-) metastatic breast cancer: a multicenter retrospective study from the Dongting Lake region of China.
Transl Breast Cancer Res
Liu B, Wu T, Lu K, Chen J, Zhou Q, Liu L, Tian C, Hu ZY, Tang Y, Ouyang Q, Xie N.
PMID: 41675004 [PubMed]


Social inequalities in survival among women with breast cancer in southeastern Brazil: a retrospective cohort study.
Transl Breast Cancer Res
Pessanha RM, Grippa WR, Neto LCBS, Dell'Antonio LS, Dell'Antonio CSDS, Lopes-Júnior LC.
PMID: 41675003 [PubMed]


Comparison of male breast cancer in China and the US: a real-world cohort study.
Transl Breast Cancer Res
Gao Y, Zhang M, Nie J, Ye G, Sun G, Ma L, Wang H, Jiang Z, Lin Y.
PMID: 41675001 [PubMed]


GNAL-driven calcium signaling reshapes the spatiotemporal immune landscape in ER(+) breast cancer: causal insights and prognostic implications.
Transl Cancer Res
Zeng J, Tian D, Zhang J, Wang G, Li Y, Yu Y, Tian Y, He J, Shen W, Chen Z.
PMID: 41674994 [PubMed]


Prognostic characteristics, recurrence patterns and survival outcomes of uterine papillary serous carcinoma: a single-centre retrospective cohort study.
Transl Cancer Res
Conforti J, Sattar A, Zouridis A, Smyth S, Darwish A, Sadeghi N, Abdalla M, Caulfield L, Trent S, Ferrari F, Pappa C, Kehoe S, Addley S, Soleymani Majd H.
PMID: 41674960 [PubMed]


   
   Articles 1 - 20 / 324301    Page 1 of 16216  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1